Axa XL has been plagued by poor underwriting performance and volatility issues, which has led its new parent to buy more reinsurance and a substantial adverse development cover, and inject an additional $1bn in capital into the business.
It
Axa XL has been plagued by poor underwriting performance and volatility issues, which has led its new parent to buy more reinsurance and a substantial adverse development cover, and inject an additional $1bn in capital into the business.
It